Wolfe Research analyst Bill Carcache downgrades SVB Finl Gr (NASDAQ:SIVB) from Outperform to Peer Perform.
Gilead Sciences’ Can Resume Injectable Lenacapavir Trial(s) For HIV Infection
The FDA has lifted the clinical hold placed on Gilead Sciences Inc’s (NASDAQ:GILD) Investigational New Drug Application to evaluate injectable lenacapavir for…